Implantable defibrillators and β-blockers in patients with left ventricular dysfunction: Economic, ethical, and legal considerations

American Heart Journal

Volumn 153, Issue 4 SUPPL., 2007, Pages 59-64

  Silver, Marc T ^a  

^a Raleigh Cardiology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL SUCCINATE; METOPROLOL TARTRATE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; ECONOMIC ASPECT; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPLANTATION; LEGAL ASPECT; MEDICAL ETHICS; PRIMARY PREVENTION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; CLINICAL TRIALS; COSTS AND COST ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; MALPRACTICE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947508187     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.021     Document Type: Article

References (21)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Poole-Wilson P.A., Swedberg K., Cleland J.G., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
4. The Beta Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 (2001) 1659-1667
5. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/failure/index.pdf.
6. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 353 (1999) 9-13
7. Packer M., Fowler M.B., Roecker E.B., et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Circulation 106 (2002) 2194-2197
8. Packer M., Bristow M.R., Cohn J.N., et al., for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
9. Hjalmarson A., Goldstein S., Fogerberg B., et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
10. Cykert S., and Greene S. The substitution of carvedilol for metoprolol in the treatment of systolic heart failure: an economic analysis of the COMET trial. [abstract]. J Gen Intern Med 19 Suppl 1 (2004) 226
11. Heidenreich P.A. Cost-effectiveness of carvedilol versus metoprolol tartrate for patients with heart failure. [abstract]. J Am Coll Cardiol 43 Suppl 2 (2004) 425A [Abstract 4]
12. Sanders G.D., Hlatky M.A., and Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353 (2005) 1471-1480
13. Mark D.B., Nelson C.L., Anstrom K.J., et al. Cost effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure. Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114 (2006) 135-142
14. Kuntz K.M., Fleischmann K.E., Hunink M.G., et al. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 130 (1999) 709-718
15. Lee T.T., Solomon N.A., Heidenreich P.A., et al. Cost-effectiveness of sreening for carotid stenosis in asymptomatic persons. Ann Intern Med 126 (1997) 337-346
16. Kuntz K.M., Tsevat J., Goldman L., et al. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation 94 (1996) 957-965
17. Wynia M.K., VanGeest J.B., Cummins D.S., et al. Do physicians not offer useful services because of coverage restrictions?. Health Affairs 22 (2003) 190-197
18. Angell M. The doctor as double agent. Kennedy Inst Ethics J 3 (1993) 279-286
19. American College of Physicians Ethics Manual. Ann Intern Med 128 (1998) 576-594
20. ACCF/AHA Consensus Conference Report on Professionalism and Ethics. Presented in Bethesda, Maryland, June 2-3, 2004. J Am Coll Cardiol 44 (2004) 1717-1761
21. Nowatske v. Osterloh, 198 Wis.2d 419, 543 N.W.2d 265, 272 (11996), from Furrow, et.al., Health Law, St. Paul, MN: West Group; 2001. p.171.